Open this publication in new window or tab >>Show others...
2024 (English)In: Journal of Hypertension, ISSN 0263-6352, E-ISSN 1473-5598, Vol. 42, no 7, p. 1226-1234Article in journal (Refereed) Published
Abstract [en]
Background: Soluble P-selectin (sP-selectin) and high-sensitivity C-reactive protein (hsCRP) have previously been associated with hypertension, but the relation with out-of-office blood pressure (BP) and coronary artery calcification score is unknown. We aimed to examine the relationship between sP-selectin, hsCRP and home BP, as well as coronary artery calcification score and carotid artery plaques.
Methods: In the Swedish CArdioPulmonary bioImage Study (SCAPIS), 5057 randomly selected participants were evaluated with office and home BP using the semi-automatic Omron M10-IT device. For this cross-sectional study, participants with sP-selectin <4 standard deviations above mean and hsCRP <5 mg/l, representing low-grade inflammation, were included. Using generalized linear models, these inflammatory markers were evaluated in relation to BP classifications, as well as coronary artery calcification score and carotid artery plaques.
Results: Of participants, 4548 were included in the analyses. The median age was 57.2 (53.4–61.2) years, and 775 (17.0%) reported taking medication for hypertension. Participants in the highest quartile of sP-selectin [odds ratio (OR) 1.67, 95% confidence interval (CI) 1.40–1.98, P < 0.001] and hsCRP [OR 2.25, (95% CI 1.89–2.60), P < 0.001] were more likely to have sustained hypertension. Participants in the highest quartile of hsCRP were also more likely to have masked hypertension, OR (95% CI) 2.31 (1.72–3.10), P < 0.001 and carotid artery plaques, OR (95% CI) 1.21 (1.05–1.38), P = 0.007.
Conclusion: Increased sP-selectin and hsCRP were independently associated with sustained hypertension. These findings indicate an association between hypertension and platelet activity, as expressed by sP-selectin.
Place, publisher, year, edition, pages
Lippincott Williams & Wilkins, 2024
Keywords
Blood pressure, selectin, CRP, inflammation, hypertension, cardiovascular disease, CACS, carotid artery plaques, masked hypertension
National Category
Clinical Medicine
Identifiers
urn:nbn:se:liu:diva-203174 (URN)10.1097/HJH.0000000000003718 (DOI)001236309700016 ()38690927 (PubMedID)
Note
Funding Agencies|Swedish Heart and Lung Foundation [2016-0315]; Knut and Alice Wallenberg Foundation [2014-0047]; Swedish Research Council [822-2013-2000]; VINNOVA (Sweden's Innovation agency) [2012-04476]; University of Gothenburg; Sahlgrenska University Hospital; Karolinska Institutet; Stockholm County council; Linkoping University; University Hospital; Lund University; Skane University Hospital; Umea University; Uppsala University; Swedish government; Swedish county councils (the ALF-agreement); Division of Primary Healthcare of Region Ostergotland; National Research School in General Practice; Swedish Society of Medicine; Swedish Society for Medical Research; Strategic Research Network in Circulation and Metabolism at Linkoping University (LiU-CircM); King Gustaf V and Queen Victoria Freemason Foundation
2024-05-012024-05-012024-08-20Bibliographically approved